Literature DB >> 3190539

Retinal blood velocity in patients with leukocyte disorders.

T Rimmer1, E M Kohner, J M Goldman.   

Abstract

The blue light entoptic phenomenon was used to measure retinal blood velocity in eight patients with chronic granulocytic leukemia, six patients with leukopenia, and matched control subjects. The retinal leukocyte velocity of the leukemic patients was 0.53 +/- 0.26 (mean +/- SD) mm/s, whereas that of the matched control subjects was 0.46 +/- 0.14 mm/s. There was no significant difference between these two groups (power: 96% for a difference of 0.2 mm/s and 66% for 0.1 mm/s). There was also no significant difference between the leukocyte velocities of the leukopenic patients and control subjects (0.47 +/- 0.19 mm/s and 0.55 +/- 0.14 mm/s, respectively; 89% power for a difference of 0.2 mm/s, 59% for 0.1). There was a correlation between the leukocyte count and the number of leukocytes seen in the entoptoscope. The results suggest that retinal vascular autoregulation can compensate for changes in leukocyte numbers that might have been expected to alter retinal blood flow.

Entities:  

Mesh:

Year:  1988        PMID: 3190539     DOI: 10.1001/archopht.1988.01060140716041

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  2 in total

1.  Visualization of blood cell contrast in nailfold capillaries with high-speed reverse lens mobile phone microscopy.

Authors:  Gregory N McKay; Nela Mohan; Ian Butterworth; Aurélien Bourquard; Álvaro Sánchez-Ferro; Carlos Castro-González; Nicholas J Durr
Journal:  Biomed Opt Express       Date:  2020-03-30       Impact factor: 3.732

2.  Non-invasive detection of severe neutropenia in chemotherapy patients by optical imaging of nailfold microcirculation.

Authors:  Aurélien Bourquard; Alberto Pablo-Trinidad; Ian Butterworth; Álvaro Sánchez-Ferro; Carolina Cerrato; Karem Humala; Marta Fabra Urdiola; Candice Del Rio; Betsy Valles; Jason M Tucker-Schwartz; Elizabeth S Lee; Benjamin J Vakoc; Timothy P Padera; María J Ledesma-Carbayo; Yi-Bin Chen; Ephraim P Hochberg; Martha L Gray; Carlos Castro-González
Journal:  Sci Rep       Date:  2018-03-28       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.